“Real‐World” Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States
Author:
Affiliation:
1. Eli Lilly and CompanyUS Medical AffairsIndianapolis Indiana
2. IMS HealthHealth Economics and Outcomes Research/Real World Evidence SolutionsPlymouth Meeting PA
3. VCU Pauley Heart CenterRichmond Virginia
Funder
Daiichi Sankyo Inc, Parsippany, NJ; Eli Lilly and Company, Indianapolis, IN
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.26279
Reference24 articles.
1. American Heart Association Statistics Committee Stroke Statistics Subcommittee. Heart disease and stroke statistics—2014 update: A report from the American Heart Association;Mozaffarian D;Circulation,2015
2. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
3. 2013 ACCF/AHA guideline for the management of ST‐elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara PT;Circulation,2013
4. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
5. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of Clinical Outcomes in Acute Coronary Syndrome Patients Who Undergo Percutaneous Coronary Intervention Using Different P2Y12 Inhibitors: A SMS Hospital Based Observational Study;2023-12-05
2. Comparative Risk of Hospitalized Bleeding of P2Y12 Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome After Percutaneous Coronary Intervention;Clinical Pharmacology & Therapeutics;2022-12-28
3. Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary Intervention;JACC: Cardiovascular Interventions;2022-11
4. Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome;Thrombosis Journal;2022-04-21
5. Evaluation of Effectiveness and Tolerability of Fondaparinux in the Management of Symptomatic Acute Coronary Syndrome: A Real-World Evidence-Based Study on an Indian Population;Cardiology and Therapy;2022-02-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3